Ernest Jones makes bold statement about Seahawks' ascending defense The most important piece in Mike Macdonald's new-look defense is ready to take on the entire NFL.

Cholangitis and cholecystitis are two conditions that share some similarities but have different causes and symptoms. Cholangitis affects the bile ducts, while cholecystitis affects the gallbladder.

Results from an interim analysis of the Phase III ASSURE trial found that Gilead’s Livdelzi (seladelpar) demonstrated sustained efficacy and a favorable safety profile in patients with primary biliary ...

Primary sclerosing cholangitis (PSC) is a chronic progressive liver disease that affects the bile ducts. About 40% of people will need a liver transplant.

Volixibat is currently being evaluated in Phase 2b studies for primary sclerosing cholangitis (VISTAS study), and primary biliary cholangitis (VANTAGE study).

Cholangitis is inflammation (swelling) in the bile duct. Treatment depends on your symptoms and whether you have chronic or acute cholangitis.

Acute calculous cholecystitis is a gallbladder inflammation that occurs due to the presence of gallstones. Learn more here.

With an FDA approval in hand for primary biliary cholangitis (PBC) treatment Livdelzi (seladelpar), Gilead Sciences enters arenas that are both new and old.

The Food and Drug Administration (FDA) has granted accelerated approval to Iqirvo ® (elafibranor) for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid ...

Cholecystitis is a condition that occurs when your gallbladder becomes inflamed. Common symptoms include abdominal pain, bloating, and nausea.